Show
Sort by
-
- Journal Article
- A2
- open access
EUFOREA summit in Brussels 2023 : inspiring the future of allergy & respiratory care
-
- Journal Article
- A1
- open access
The unified airway hypothesis : evidence from specific intervention with anti–IL-5 biologic therapy
-
- Journal Article
- A2
- open access
Chronic rhinosinusitis : matching the extent of surgery with pathology or does the extent of surgery matter?
-
- Journal Article
- A1
- open access
The indispensable nasal decongestant : patients' views and perspectives on nasal decongestant overuse
-
The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps
-
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis
-
COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies
-
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps : a randomized, placebo-controlled trial
-
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a Phase 1 study